tirzepatide 11.25 mg In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Tirzepatide vs Semaglutide | Best

Acute pancreatitis has been reported with incretin-based therapies, and patients with a history of pancreatitis may be at increased risk for recurrence

We review the complexity of GIP in regulating adipose tissue function and energy balance in the context of recent findings in T2DM showing that dual GIP/GLP-1 receptor agonist therapy produces profound weight loss, glycemic control, and lipid lowering

A licensed provider will review your information to determine if you're a candidate for treatment

For diabetics, Mounjaro also increases insulin production, lowering blood sugar levels

Please speak to a licensed medical professional to see if GLP-1 medication assisted weight loss is safe and right for you

Higher doses correlate with higher rates of skin sensitivity